What is Avian Influenza H5N1?

Avian influenza H5N1 is a highly pathogenic bird flu virus that primarily infects wild birds and poultry. However, in recent years, this virus has increasingly been found in mammals, raising concerns about its potential to adapt for human transmission. H5N1 has a high mortality rate in both birds and humans and is closely monitored by global health agencies.

Recent Developments

Since 2022, outbreaks of H5N1 have been detected in a variety of mammals including sea lions, seals, foxes, mink, cats, and even dairy cows. In 2024, a case of human infection from infected cattle was reported in the United States. These cross-species transmissions raise alarms about viral mutations that could lead to easier human-to-human spread.

Causes

Direct contact with infected birds or their secretions
Consumption of infected raw poultry or contaminated milk
Close contact with infected mammals (e.g., livestock, pets)
Possible airborne transmission in dense animal populations (e.g., mink farms)

Common Symptoms in Humans

Symptoms usually develop within a few days of exposure and may include:

High fever
Cough and sore throat
Shortness of breath
Muscle aches
Diarrhea or abdominal pain
Eye infections (in some cases)
Rapid progression to severe pneumonia or acute respiratory distress syndrome (ARDS)

Diagnosis

Diagnosis is based on:

PCR testing for H5N1 viral RNA
Viral culture and antigen detection
Chest X-ray or CT scan in case of pneumonia
History of exposure to infected birds or animals

Treatment

Antiviral medications (such as oseltamivir or zanamivir) are most effective when given early
Hospitalization may be required for respiratory support
Supportive care for fever, hydration, and lung function
Close monitoring of respiratory complications

Prognosis

The human fatality rate for H5N1 has been estimated at over 50% in past outbreaks
Early detection and treatment improve outcomes
New cases are rare but potentially serious